Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Zhongping Lily Mao
Based on 2 articles published since 2010
(Why 2 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 2 published articles on Parkinson Disease from 2010 through 2020, it is not possible for Expertscape to reliably rate Zhongping Lily Mao's expertise on this topic.

Aliases Mao, Zhongping   ·   Mao, Zhongping Lily
Work Locations
Details
Most likely:    Miscellaneous cities in California      
2016
  • Impax Specialty Pharma, a division of Impax Laboratories, Inc, Hayward, CA, USA. · Pubmed 26632091
2013
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Zhongping Lily Mao in 2010-2020 about Parkinson Disease:

  • Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease. 2016
  • Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease. 2013
Show List of Full Article Records
Google Searches

Learn more about Zhongping Lily Mao using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in California
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in California
2016
  • Impax Specialty Pharma, a division of Impax Laboratories, Inc, Hayward, CA, USA. · Pubmed 26632091
2013
Yearly article counts 00001001000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.